{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:48:14Z","timestamp":1781333294579,"version":"3.54.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5U01PS005259"],"award-info":[{"award-number":["5U01PS005259"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Long-acting injectable antiretroviral therapy (LAI-ART) offers an alternative to daily oral treatment but is typically administered in clinics, which can create barriers for some people with HIV (PWH). Home-based administration by trained treatment buddies (TBYs)\u2014trusted partners, friends, or family members\u2014has not been systematically studied. We conducted semi-structured interviews with 31 participants (16 PWH and 15 TBYs) across 4 HIV clinics in the San Francisco Bay Area between June 2024 and April 2025. Guided by the Consolidated Framework for Implementation Research (CFIR), interviews explored anticipated facilitators, barriers, and training needs for home-based LAI-ART. Participants identified several anticipated benefits of home-based LAI-ART, including increased convenience, reduced transportation burdens, enhanced privacy, comforting and emotionally supportive care, and opportunities to foster empowerment and shared responsibility between PWH and TBYs. Key barriers included concerns about medication storage and delivery logistics, maintaining reliable injection schedules, needlestick safety, and the readiness and confidence of TBYs. Participants emphasized the need for hands-on training, ongoing support, and clear protocols to ensure safe, acceptable, and effective home-based administration. These findings underscore the importance of proactive planning and tailored support in addressing both the technical and emotional dimensions of home-based LAI-ART. Anticipating these needs can facilitate the successful implementation and expand access to person-centered HIV care.<\/jats:p>","DOI":"10.1371\/journal.pone.0341173","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:32:30Z","timestamp":1773077550000},"page":"e0341173","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0268-9277","authenticated-orcid":true,"given":"Alicia T.","family":"Bolton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7537-6350","authenticated-orcid":true,"given":"Beth","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Rebchook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Van Nuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Buchacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"pone.0341173.ref001","author":"National HIV Strategic Plan (2022-2025)","year":"2022"},{"key":"pone.0341173.ref002","volume-title":"Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 territories and freely associated states, 2022","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"pone.0341173.ref003","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CEOR.S520050","article-title":"Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987-2023","volume":"17","author":"AT Paquete","year":"2025","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"pone.0341173.ref004","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae265","article-title":"Patient attitudes toward self- or partner-, friend-, or family-administered long-acting injectable antiretroviral therapy: a mixed-methods study across 3 urban human immunodeficiency virus clinics","volume":"11","author":"LF Collins","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"pone.0341173.ref005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/09540121.2020.1764906","article-title":"Acceptability and preferences for long-acting antiretroviral formulations among people with HIV infection","volume":"33","author":"D Dandachi","year":"2021","journal-title":"AIDS Care"},{"key":"pone.0341173.ref006","article-title":"U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment","author":"SM Graham","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"pone.0341173.ref007","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/09540121.2023.2240067","article-title":"Preferences of people living with HIV for injectable and oral antiretroviral treatment in the Netherlands: a discrete choice experiment","volume":"36","author":"IEH Kremer","year":"2024","journal-title":"AIDS Care"},{"issue":"7","key":"pone.0341173.ref008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/apc.2024.0093","article-title":"Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain","volume":"38","author":"C Moreno","year":"2024","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"pone.0341173.ref009","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/apc.2018.0198","article-title":"Long-acting injectable antiretroviral treatment acceptability and preferences: a qualitative study among US providers, adults living with HIV, and parents of youth living with HIV","volume":"33","author":"JM Simoni","year":"2019","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"pone.0341173.ref010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/17512433.2018.1453805","article-title":"Treatment and prevention of HIV infection with long-acting antiretrovirals","volume":"11","author":"L Ben\u00edtez-Guti\u00e9rrez","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"pone.0341173.ref011","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nm0414-323","article-title":"Long-acting HIV drugs advanced to overcome adherence challenge","volume":"20","author":"E Dolgin","year":"2014","journal-title":"Nat Med"},{"issue":"2","key":"pone.0341173.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245955","article-title":"Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study","volume":"16","author":"B Parker","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"pone.0341173.ref013","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciu046","article-title":"Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials","volume":"58","author":"JB Nachega","year":"2014","journal-title":"Clin Infect Dis"},{"key":"pone.0341173.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac716","article-title":"Barriers to uptake of long-acting antiretroviral products for treatment and prevention of human immunodeficiency virus (HIV) in high-income countries","volume":"75","author":"SE Cooper","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0341173.ref015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0000000000002337","article-title":"Multisite study of women living with HIV\u2019s perceived barriers to, and interest in, long-acting injectable antiretroviral therapy","volume":"84","author":"MM Philbin","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"pone.0341173.ref016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/apc.2024.0076","article-title":"\u201cI feel like i don\u2019t even have HIV anymore\u201d-facilitators, barriers, and experience regarding use of long-acting injectable antiretroviral therapy among persons with HIV in North Carolina","volume":"38","author":"H Agarwal","year":"2024","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"pone.0341173.ref017","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1007\/s10461-021-03357-y","article-title":"Transgender Women\u2019s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)","volume":"25","author":"CT Rael","year":"2021","journal-title":"AIDS Behav"},{"issue":"7","key":"pone.0341173.ref018","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s10461-024-04315-0","article-title":"Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States","volume":"28","author":"XA Erguera","year":"2024","journal-title":"AIDS Behav"},{"issue":"4","key":"pone.0341173.ref019","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/COH.0000000000000158","article-title":"Implementation challenges for long-acting antivirals as treatment","volume":"10","author":"D Havlir","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"pone.0341173.ref020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/aid.2020.0126","article-title":"The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review","volume":"37","author":"JT Kanazawa","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"pone.0341173.ref021","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10461-019-02701-7","article-title":"A conjoint analysis of the acceptability of targeted long-acting injectable antiretroviral therapy among persons living with HIV in the U.S","volume":"24","author":"JM Simoni","year":"2020","journal-title":"AIDS Behav"},{"issue":"9","key":"pone.0341173.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26003","article-title":"Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE)","volume":"25","author":"M Czarnogorski","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"pone.0341173.ref023","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000003743","article-title":"Enthusiasm for participation in a novel, at-home delivery model for injectable hiv treatment among people With HIV","volume":"100","author":"M Palomares","year":"2025","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0341173.ref024","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000003128","article-title":"Preferences for HIV treatment formulations among young adults with HIV in the United States","volume":"92","author":"P Saberi","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0341173.ref025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0000000000001896","article-title":"Interest of youth living with HIV in long-acting antiretrovirals","volume":"80","author":"ED Weld","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0341173.ref026","article-title":"Comparison of at-home versus in-clinic receipt of long-acting injectable cabotegravir\/rilpivirine","author":"SE Kirk","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1178","key":"pone.0341173.ref027","article-title":"Preferences of people living with HIV for long-acting antiretroviral treatment in Germany: evidence from a discrete choice experiment","volume":"16","author":"M Emmert","year":"2023","journal-title":"Patient"},{"issue":"8","key":"pone.0341173.ref028","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097921","article-title":"Innovative administration of long-acting injectables for HIV treatment enhancement at home (INVITE-HOME): implementation science study protocol","volume":"15","author":"B Bourdeau","year":"2025","journal-title":"BMJ Open"},{"key":"pone.0341173.ref029","doi-asserted-by":"crossref","DOI":"10.1177\/1609406920937875","article-title":"Qualitative Data Collection in an Era of Social Distancing","volume":"19","author":"B Lobe","year":"2020","journal-title":"International Journal of Qualitative Methods"},{"key":"pone.0341173.ref030","volume-title":"Dedoose Version 9.0.107. Cloud application for managing, analyzing, and presenting qualitative and mixed method research data","year":"2023"},{"key":"pone.0341173.ref031","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"LJ Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"1","key":"pone.0341173.ref032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated consolidated framework for implementation research based on user feedback","volume":"17","author":"LJ Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"pone.0341173.ref033","article-title":"Development of secure infrastructure for advancing generative AI research in healthcare at an academic medical center","author":"MY Ng","year":"2024","journal-title":"Res Sq"},{"issue":"10","key":"pone.0341173.ref034","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/ACM.0000000000006134","article-title":"Artificial Intelligence to Support Qualitative Data Analysis: Promises, Approaches, Pitfalls","volume":"100","author":"DA Cook","year":"2025","journal-title":"Acad Med"},{"issue":"1","key":"pone.0341173.ref035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jmwh.13190","article-title":"Evidence-based guidance for self-administration of injectable contraception","volume":"66","author":"M Marx","year":"2021","journal-title":"J Midwifery Womens Health"},{"key":"pone.0341173.ref036","doi-asserted-by":"crossref","first-page":"890017","DOI":"10.3389\/fgwh.2022.890017","article-title":"Contraceptive self-injection through routine service delivery: Health worker perspectives from Uganda","volume":"3","author":"C Morozoff","year":"2022","journal-title":"Front Glob Womens Health"},{"issue":"1","key":"pone.0341173.ref037","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1186\/s12889-018-6015-3","article-title":"A qualitative evaluation of hospital versus community-based management of patients on injectable treatments for tuberculosis","volume":"18","author":"DB Cohen","year":"2018","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0341173.ref038","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thoraxjnl-2018-212675","article-title":"Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trial","volume":"75","author":"DB Cohen","year":"2020","journal-title":"Thorax"},{"key":"pone.0341173.ref039","unstructured":"Dieterich M, Patel R, Gouzoulis M, Richardson K, Kelley E, Bangert R. Home CAB\/RPV provides novel approach to achieve viral suppression in PWH with adherence challenges. 2025."}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:32:36Z","timestamp":1773077556000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341173"}},"subtitle":[],"editor":[{"given":"Wondwossen Amogne","family":"Degu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341173","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}